Rigel Pharmaceuticals, Inc. (RIGL) by event type
RIGL moves most on analyst downgrades — a median of -0.62% at 30 minutes across 14 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the RIGL overview →
How RIGL reacts across 4 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 1,631 of 2,717 | 21 | -0.07% | 38% | -1.39% |
| Analyst downgrades 2,287 of 2,603 | 14 | -0.62% | 43% | -1.11% |
| Rating reiterations 400 of 3,522 | 63 | +0.23% | 56% | +0.30% |
| Price-target raises 1,718 of 1,790 | 12 | -0.49% | 42% | -1.74% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 1 further class was observed with fewer than 10 measured events and is not published.
That’s how RIGL usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Rating reiterations → · Price-target raises → · RIGL overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| GEMPHIRE THERAPEUTICS INC COMMON (GEMP) | 282 | -1.00% | 30% |
| PRINCIPIA BIOPHARMA INC COMMON (PRNB) | 282 | +0.23% | 59% |
| Arcturus Therapeutics Holdings Inc. (ARCT) | 279 | -0.52% | 36% |
| CORREVIO PHARMA CORP ORDINARY SHARES (CORV) | 279 | 0.00% | 44% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.